AN2 Therapeutics Inc

NASDAQ ANTX

Data sourced from iex and EODHD
Download Data

AN2 Therapeutics Inc Income Statement 2019 - 2023

This table shows the Income Statement for AN2 Therapeutics Inc going from 2019 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Revenue
M 0 0 0 0 -
Cost of Revenue
M - 0 - - -
Gross Profit
M - 0 - - -
Operating Expenses
M - 42 - - -
Selling, General, and Administrative Expenses (SG&A)
M 15 13 5 1 -
Research and Development (R&D) Expenses
M 55 30 17 6 -
Other Operating Expenses
M - 0 - - -
Costs and Expenses
M - 42 - - -
Operating Income
M -70 -42 -22 -7 -
Interest Expense
M - 1 0 0 0
Non-operating Income/Expense
M 5 1 0 -6 -
EBT
M -65 -41 -22 -14 -
Income Tax Provision
M 0 1 0 0 -
Income after Tax
M -65 -41 -21 -14 -
Non-Controlling Interest
M - 2 7 1 -
Net Income
M - -43 -28 -15 -34
Shares (Basic, Weighted)
M - - - - -
Shares (Diluted, Weighted)
R 23,600,107.00 19,402,658.00 18,739,786.00 18,739,786.00 -
EBITDA
M -70 -43 -21 -7 -
Depreciation and Amortization
M 70 -1 0 0 -
EBIT
M -139 -42 -22 -7 -31
Income from Discontinued Operations
M - - - - -
Tax Rate (Effective)
% 0.11 -1.26 0.32 0.02 -
Earnings Per Share (EPS), Basic
M - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 -
Gross Profit Margin
% - - - - -
Operating Income Margin
% - - - - -
Net Income Margin
% - - - - -
EBITDA Ratio
% - - - - -
EBIT Ratio
% - - - - -
EBT Ratio
% - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email